The Patent Finder

Mitos Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Mitos Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Mitos Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 8,563,581Nitroxides for Use in Treating Predisposed or at Risk Patients
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,625,928Nitroxide Radioprotector Formulations and Methods of Use
Formerly held
Term ended
Term ended Sep 14, 2026 · High confidence
Term endedTerm ended Sep 14, 2026High confidence
US 10,245,256Nitroxides for Use in Treating or Preventing Diabetes and Obesity
Formerly held
Term ended
Term ended Jun 4, 2026 · High confidence
Term endedTerm ended Jun 4, 2026High confidence
US 9,101,619Nitroxides for Use in Treating or Preventing Diabetes and Obesity
Formerly held
Term ended
Term ended Feb 2, 2026 · High confidence
Term endedTerm ended Feb 2, 2026High confidence
US 9,522,143Nitroxides for Use in Treating or Preventing Diabetes and Obesity
Formerly held
Term ended
Ended no later than Feb 2, 2026 · Medium confidence
Term endedEnded no later than Feb 2, 2026Medium confidence
US 9,522,144Nitroxides for Use in Treating or Preventing Diabetes and Obesity
Formerly held
Term ended
Term ended Feb 2, 2026 · High confidence
Term endedTerm ended Feb 2, 2026High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited